Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-18-013244

Director sold 44,000 shares at an average $57.99 ($2,551,440)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2018-05-15 Sale −43,000 $57.97 $2,492,710 641,014 I
Bolzon Bradley J PhD Director 2018-05-15 Sale −1,000 $58.73 $58,730 640,014 I
Open-market sales · 44,000 sh · avg $57.99 · $2,551,440
Loading xslF345X03/doc4.xml…